Posts
News
Latest
Hot
Unlock Pro Investors’ Money-Making Secrets
Join Futubull Community! Now Connect Directly with Top Investors & Public Company Executives
Xuanzhu Biotech opened more than 150% higher on its first day. Would you still consider investing?
Xuanzhu Bio, an innovative drug IPO, opened higher on its first trading day, surging over 150%. As an innovation-driven biopharmaceutical co
Xuanzhu Bio, an innovative drug IPO, opened higher on its first trading day, surging over 150%. As an innovation-driven biopharmaceutical company in China, its R&D pipeline covers areas such as digestive system diseases, oncology, and NASH, with 20 IND approvals. Despite remaining in the loss-making stage currently, the company’s commercialization potential deserves attention. Would you still consider investing? What is your take on Xuanzhu Bio’s performance on its first day of listing?
Views
1.1M
Posts
330
Follow
Join topic
Related Stocks
No Data
Overview of Popular IPO Performances on the First Trading Day
Similar Topics
More
- 2026 IPO bonanza! Over 90% of new stocks rose on their debut70.1M Views · 18K Posts
- Is the Gray Market Surge Just the Beginning? GenFleet Therapeutics Soars Over 140% on Debut!1.3M Views · 508 Posts
- Zijin Mining and XPL Soar on Debut! Is It Too Late to Buy In?9.3M Views · 1412 Posts
- Dahon Tech's stock opened 36% higher on its first day. Should we take profits or double down?1.3M Views · 197 Posts
- The world's first tokenized security IPO is currently open for subscription!3.7M Views · 267 Posts